rasagiline 0.5 MG Oral Tablet [Azilect]
rasagiline
RxCUI: 637218
What the CMS Formulary Data Shows for rasagiline 0.5 MG Oral Tablet [Azilect]
Per the CMS 2026 Part D formulary file, rasagiline 0.5 MG Oral Tablet [Azilect] (RxNorm concept RXCUI 637218, generic name rasagiline) appears on 1 distinct formulary file spanning 2 Medicare Part D plan offerings - 0% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 1, with a cross-plan average of Tier 1.
Real-world access to rasagiline 0.5 MG Oral Tablet [Azilect] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 30,404 Part D beneficiaries filled rasagiline 0.5 MG Oral Tablet [Azilect] in 2023, with total plan-and-beneficiary spending of $43,873,454 and an average per-beneficiary annual cost of $1,443.02. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry rasagiline 0.5 MG Oral Tablet [Azilect] today.
Coverage Details
- Formularies covering
- 1
- Plans covering
- 2
- Coverage rate
- 0%
- Tier range
- Tier 1, Preferred Generic
- Average tier
- Tier 1, Preferred Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 30,404
- Total spending
- $43,873,454
- Avg per beneficiary
- $1,443.02
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering rasagiline 0.5 MG Oral Tablet [Azilect]
2 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $0 | NY |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $34.50 | NY |
Frequently Asked Questions
Is rasagiline 0.5 MG Oral Tablet [Azilect] covered by Medicare Part D?
Yes, rasagiline 0.5 MG Oral Tablet [Azilect] is covered by 2 Medicare Part D plans (0% of all Part D formularies).
What tier is rasagiline 0.5 MG Oral Tablet [Azilect] on Medicare Part D plans?
rasagiline 0.5 MG Oral Tablet [Azilect] averages Tier 1 across Part D plans, ranging from Tier 1 to Tier 1.
Does rasagiline 0.5 MG Oral Tablet [Azilect] require prior authorization?
0% of Part D formularies require prior authorization for rasagiline 0.5 MG Oral Tablet [Azilect]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on rasagiline 0.5 MG Oral Tablet [Azilect]?
In 2023, total Medicare Part D spending on rasagiline 0.5 MG Oral Tablet [Azilect] was $43,873,454, covering 30,404 beneficiaries. The average spend per beneficiary was $1,443.02.
Read our methodology - how this data is sourced, computed, and verified.